Cargando…

The use and quality of reporting of propensity score methods in multiple sclerosis literature: A review

BACKGROUND: Propensity score (PS) analyses are increasingly used in multiple sclerosis (MS) research, largely owing to the greater availability of large observational cohorts and registry databases. OBJECTIVE: To evaluate the use and quality of reporting of PS methods in the recent MS literature. ME...

Descripción completa

Detalles Bibliográficos
Autores principales:	Karim, Mohammad Ehsanul, Pellegrini, Fabio, Platt, Robert W, Simoneau, Gabrielle, Rouette, Julie, de Moor, Carl
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	SAGE Publications 2020
Materias:	Topical Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9260477/ https://www.ncbi.nlm.nih.gov/pubmed/33179573 http://dx.doi.org/10.1177/1352458520972557

Ejemplares similares

Recommendations for the use of propensity score methods in multiple sclerosis research
por: Simoneau, Gabrielle, et al.
Publicado: (2022)

Methods for comparative effectiveness based on time to confirmed disability progression with irregular observations in multiple sclerosis
por: Debray, Thomas PA, et al.
Publicado: (2023)

Evaluation of propensity score used in cardiovascular research: a cross-sectional survey and guidance document
por: Samuel, Michelle, et al.
Publicado: (2020)

Neuromodulation for functional bladder disorders in patients with multiple sclerosis
por: Rahnama’i, Mohammad Sajjad
Publicado: (2019)

Overall and patient-specific comparative effectiveness of dimethyl fumarate versus teriflunomide: A novel approach to precision medicine applied to the German NeuroTrans Data Multiple Sclerosis Registry
por: Jiang, Xiaotong, et al.
Publicado: (2023)

The Multiple Sclerosis Care Unit
por: Soelberg Sorensen, Per, et al.
Publicado: (2018)

Measuring the cost-effectiveness of treatments for people with multiple sclerosis: Beyond quality-adjusted life-years
por: Hawton, Annie, et al.
Publicado: (2020)

Pregnancy, sex and hormonal factors in multiple sclerosis
por: Miller, David H, et al.
Publicado: (2014)

Decentralised clinical trials in multiple sclerosis research
por: Garjani, Afagh, et al.
Publicado: (2022)

In vivo imaging of chronic active lesions in multiple sclerosis
por: Calvi, Alberto, et al.
Publicado: (2020)

Is Clostridium perfringens epsilon toxin associated with multiple sclerosis?
por: Titball, Richard W, et al.
Publicado: (2023)

Alemtuzumab: A new therapy for active relapsing–remitting multiple sclerosis
por: Hartung, Hans-Peter, et al.
Publicado: (2015)

What’s in a name? That which we call Multiple Sclerosis Fatigue
por: Hubbard, Amy Lynn, et al.
Publicado: (2020)

Retinal imaging with optical coherence tomography in multiple sclerosis: novel aspects
por: Olbert, Elisabeth, et al.
Publicado: (2022)

Combination of docetaxel versus nonsteroidal antiandrogen with androgen deprivation therapy for high-volume metastatic hormone-sensitive prostate cancer: a propensity score-matched analysis
por: Yanagisawa, Takafumi, et al.
Publicado: (2022)

Neuromyelitis optica and multiple sclerosis: Seeing differences through optical coherence tomography
por: Bennett, JL, et al.
Publicado: (2015)

“No evident disease activity”: The use of combined assessments in the management of patients with multiple sclerosis
por: Giovannoni, Gavin, et al.
Publicado: (2017)

Wearable technologies to measure clinical outcomes in multiple sclerosis: A scoping review
por: Alexander, Sarah, et al.
Publicado: (2020)

Comparative effectiveness of natalizumab on cognition in multiple sclerosis: A cohort study
por: Manouchehrinia, Ali, et al.
Publicado: (2023)

Real-world evidence for cladribine tablets in multiple sclerosis: further insights into efficacy and safety
por: Moser, Tobias, et al.
Publicado: (2022)

Effect of a community intervention programme promoting social interactions on functional disability prevention for older adults: propensity score matching and instrumental variable analyses, JAGES Taketoyo study
por: Hikichi, Hiroyuki, et al.
Publicado: (2015)

Mechanisms of action of adrenocorticotropic hormone and other melanocortins relevant to the clinical management of patients with multiple sclerosis
por: Arnason, Barry G, et al.
Publicado: (2013)

Overall and patient-level comparative effectiveness of dimethyl fumarate and fingolimod: A precision medicine application to the Observatoire Français de la Sclérose en Plaques registry
por: Simoneau, Gabrielle, et al.
Publicado: (2022)

COVID-19 COMPLICATED BY RESPIRATORY FAILURE INCREASES INPATIENT STEMI MORTALITY: MACHINE LEARNING-AUGMENTED MODIFIED PROPENSITY SCORE ADJUSTED LONGITUDINAL COHORT STUDY
por: Ynalvez, Leslie Ammabel, et al.
Publicado: (2023)

Fatigue, depression, and pain in multiple sclerosis: How neuroinflammation translates into dysfunctional reward processing and anhedonic symptoms
por: Heitmann, Henrik, et al.
Publicado: (2020)

T cell responses to COVID-19 infection and vaccination in patients with multiple sclerosis receiving disease-modifying therapy
por: Reder, Anthony T, et al.
Publicado: (2022)

Cerebrospinal fluid kappa free light chains as biomarker in multiple sclerosis—from diagnosis to prediction of disease activity
por: Hegen, Harald, et al.
Publicado: (2022)

Modifiable risk factors for poor health outcomes in multiple sclerosis: The urgent need for research to maximise smoking cessation success
por: Marck, Claudia H, et al.
Publicado: (2019)

An overview of pivotal trials and real-world evidence for CD20-depleting therapy in multiple sclerosis: Immunotherapy with rituximab, ocrelizumab, and ofatumumab
por: Ovchinnikov, Arkady, et al.
Publicado: (2022)

Quality of life outcomes in patients with localised renal cancer: a literature review
por: Rossi, Sabrina H., et al.
Publicado: (2018)

Sex and age differences in the Multiple Sclerosis prodrome
por: Yusuf, Fardowsa L. A., et al.
Publicado: (2022)

Methodological Investigation of Time Perspective Scoring and Quality of Life among Individuals with Multiple Sclerosis
por: Carl, Ellen, et al.
Publicado: (2022)

Detection and Monitoring of Interstitial Lung Disease in Patients with Systemic Sclerosis
por: Khanna, Surabhi Agarwal, et al.
Publicado: (2022)

Multiple Sclerosis in Older Adults: The Clinical Profile and Impact of Interferon Beta Treatment
por: Shirani, Afsaneh, et al.
Publicado: (2015)

Comparative effectiveness of natalizumab versus ocrelizumab in multiple sclerosis: a real-world propensity score–matched study
por: Pape, Katrin, et al.
Publicado: (2022)

Pain in persons who are marginalized by social conditions
por: Craig, Kenneth D., et al.
Publicado: (2020)

New Prospects for Ultra-High-Field Magnetic Resonance Imaging in Multiple Sclerosis
por: Ineichen, Benjamin V., et al.
Publicado: (2021)

Extensive Healthy Donor Age/Gender Adjustments and Propensity Score Matching Reveal Physiology of Multiple Sclerosis Through Immunophenotyping
por: Hannikainen, Paavali A., et al.
Publicado: (2020)

Chicken or the egg: ST elevation in lead aVR or SYNTA X score
por: Cerit, Levent
Publicado: (2017)

Typical aspects in the rehabilitation of cancer patients suffering from metastatic bone disease or multiple myeloma
por: Keilani, Mohammad, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_hs3m61d3f3ik5k4bgslpqvii40